Cart summary

You have no items in your shopping cart.

Anti-CD79b Reference Antibody (polatuzumab vedotin-piiq)

Catalog Number: orb1805469

DispatchUsually dispatched within 5-10 working days
$ 250.00
Catalog Numberorb1805469
CategoryAntibodies
DescriptionAnti-CD79b Reference Antibodyected antibody and Monomethyl auristatin E (MMAE) that can be used in combination with bendamustine and rituximab for the treatment of adult patients with at least two relapses or refractory diffuse large B-cell lymphoma. Polatuzumab vedotin binds to CD79b and is internalized by tumor cells. MMAE is cleaved from cells by lysosomal protease and promotes tumor cell apoptosis by inhibiting microtubule formation.
ClonalityMonoclonal
Tested applicationsELISA, FA, FACS, Kinetics
ReactivityHuman
IsotypeIgG
Purity> 95%
ConjugationUnconjugated
MW145.5 kDa
TargetCD79b
Endotoxins< 1 EU/mg
StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Buffer/Preservatives100 mM Pro-Ac 20 mM Arg pH 5.0
NoteFor research use only
Expiration Date12 months from date of receipt.
Anti-CD79b Reference Antibody (polatuzumab vedotin-piiq)

Anti-CD79b Reference Antibody (polatuzumab vedotin-piiq) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

Anti-CD79b Reference Antibody (polatuzumab vedotin-piiq)

The purity of Anti-CD79b Reference Antibody (polatuzumab vedotin-piiq)is more than 95% ;determined by SEC-HPLC.

Anti-CD79b Reference Antibody (polatuzumab vedotin-piiq)

Immobilized human CD79b; His Tag at 2 μg/mL can bind Anti-CD79b Reference Antibody (polatuzumab vedotin-piiq);EC50=0.005029μg/mL.